Apeiron Biologics AG - Isqette - Ownership and Business Overview

Life ScienceCompany

Apeiron Biologics AG - Isqette Ownership

Who owns Apeiron Biologics AG - Isqette?

Apeiron Biologics AG - Isqette is owned by EUSA Pharma. It was acquired on October 4, 2016.

Apeiron Biologics AG - Isqette Business Overview

Where is Apeiron Biologics AG - Isqette headquartered?

Apeiron Biologics AG - Isqette is headquartered in Langhorne, Pennsylvania.

What sector is Apeiron Biologics AG - Isqette in?

Apeiron Biologics AG - Isqette is a life science company.

Life Science M&A Summary in 2016

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Join Mergr to view all 295 acquisitions of life science companies in 2016, including 33 acquisitions by private equity firms, and 262 by strategics.

Apeiron Biologics AG - Isqette (Dinutuximab Beta)

Langhorne, Pennsylvania 19047
United States,

Apeiron Biologics AG - Isqette (Dinutuximab Beta) is an immunotherapy has orphan drug designation in the US and EU and is currently under review for marketing authorization by the EMA.


 Subscribe to unlock this and 208,602
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.